Solid Biosciences Inc. Quarterly Depreciation in USD from Q1 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Solid Biosciences Inc. quarterly/annual Depreciation history and growth rate from Q1 2017 to Q4 2023.
  • Solid Biosciences Inc. Depreciation for the quarter ending December 31, 2023 was $587K, a 8.91% increase year-over-year.
  • Solid Biosciences Inc. Depreciation for the twelve months ending December 31, 2023 was $2.58M, a 7.18% increase year-over-year.
  • Solid Biosciences Inc. annual Depreciation for 2023 was $2.58M, a 7.18% increase from 2022.
  • Solid Biosciences Inc. annual Depreciation for 2022 was $2.41M, a 18.8% decline from 2021.
  • Solid Biosciences Inc. annual Depreciation for 2021 was $2.96M, a 24.4% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $2.58M $587K +$48K +8.91% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $2.53M $588K +$150K +34.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $2.38M $703K -$19K -2.63% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.4M $703K -$6K -0.85% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.41M $539K -$221K -29.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $2.63M $438K -$314K -41.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $2.94M $722K +$4K +0.56% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $2.94M $709K -$25K -3.41% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $2.96M $760K -$36K -4.52% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 $3M $752K -$14K -1.83% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $3.01M $718K -$616K -46.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $3.63M $734K -$292K -28.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q4 2020 $3.92M $796K -$10K -1.24% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 $3.93M $766K +$2K +0.26% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $3.93M $1.33M +$676K +103% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $3.25M $1.03M +$430K +72.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $2.82M $806K +$325K +67.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-14
Q3 2019 $2.5M $764K +$219K +40.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $2.28M $658K +$345K +110% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.94M $596K +$369K +163% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.57M $481K +$258K +116% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 $1.31M $545K +$435K +395% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $873K $313K +$249K +389% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $624K $227K +$176K +345% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 $448K $223K Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $110K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $64K Mar 30, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $51K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.